Category Archives: Coronary Heart Diseases

Introduction Cardiovascular diseases (CVDs) remain the main cause of death worldwide,1 and over two-thirds of these deaths occur in developing countries.2 One of the most common CVDs is Coronary Heart Disease (CHD),3 and its treatments and controlling factors affecting outcomes are of fundamental significance for health systems. Coronary Artery Bypass Graft Surgery (CABG) is the most appropriate management for CHD when less invasive medical options are not appropriate. CABG is a common surgery for those patients because of its beneficial outcomes.36 This is evident as nearly one million CABG surgeries were done worldwide since more than ten years ago.6 Successful CABG outcomes include improved patient well-being and efficient status, reduced signs and symptoms of disability, decreased anxiety and depressive symptoms (DS), and improved quality of life.4,5,7,8 Nevertheless, CABG itself is a worrying and disturbing incident for patients, known to be accompanied by undesirable psychosomatic results in both the preoperative and postoperative periods.9,10 Furthermore, some negative consequences following this surgery remain unresolved.4,6,11,12 For example, more than a third of patients complain of chest pain, and roughly half of them have activity restriction one year later.11 Thus, recognizing changeable associated factors contributing to these adverse outcomes might improve patients reaction after CABG Continue reading →

SEATTLE, April 12, 2021, (PHARMIWEB) Global Antiplatelet Drugs Market Antiplatelet drugs are prescribed to individuals with a history of heart attacks, and these drugs aid in reducing the chances of a recurrence of heart attacks. Continue reading →

Pune, India, April 08, 2021 (GLOBE NEWSWIRE) -- According to our new research study on Microcatheters Market Forecast to 2027 COVID-19 Impact and Global Analysis by Indication and End User, the Microcatheters Market was valued at US$ 410.00 million in 2019 and is projected to reach US$ 773.05 million by 2027; it is expected to grow at a CAGR of 8.4% during 20202027. The product recall and stringent regulatory requirements, and the lack of expert professionals are the major factors hindering the market growth. Microcatheters Market: Key Insights In 2019, North America dominated the microcatheters market with more than one-third revenue share Continue reading →

Because many patients with psoriasis also have cardiovascular diseases, these comorbidities must be considered when deciding on a treatment plan, according to investigators in a new article published in Chinese Medical Journal. Continue reading →

Coronary Stents Market is valued at USD 7871.12 Million in 2018 and expected to reach USD 10487.93 Million by 2025 with the CAGR of 4.90% over the forecast period. Continue reading →

According to The Insight Partners market research study titledCardiovascular Devices Market to 2027 Global Analysis and Forecasts by Device, Application, End User and Geography.The global cardiovascular devices market is expected to reach US$ 71.1 Bn in 2027 from US$ 40.8 Bn in 2018. The market is estimated to grow with a CAGR of 6.5% from 2019-2027. Continue reading →

After following a group of more than 3,000 volunteers for more than two decades, American researchers listed consumption They are called ultra-processed foods Incidence of cardiovascular disease such as heart attack, stroke and death. These foods are those that are undergoing intense industrial transformation, such as instant noodles, soft drinks, crackers, and packaged snacks. It is common for these foods to contain preservatives, dyes, flavors, and other compounds in order to increase taste and shelf life. Continue reading →

Added on April 13, 2021 Other View By Dr Balbir Singh Heart being one of the most vital organs of the body has a major role to play. It pumps the oxygenated blood through the arteries and receives the de-oxygenated blood through the veins. Continue reading →

Introduction Cardiovascular disease (CVD) is the most common cause of death globally.1,2 In China, 7.7 million people died from CVDs in 2015; of these deaths, 7.4 million deaths were attributed to coronary artery disease (CAD).3,4 Percutaneous coronary intervention (PCI) has the benefits of less trauma and rapid recovery and has been widely used in clinical practice as the main treatment for CAD.5,6 However, PCI could only temporarily solve mechanical stenosis of the coronary arteries and is unable to prevent disease progression. In the presence of risk factors for the disease, patients are prone to adverse cardiac events such as stent stenosis and angina pectoris.7 As an effective intervention, cardiac rehabilitation (CR) has been shown to significantly reduce the incidence of adverse cardiac events in patients after undergoing PCI, which is important for improving patient prognosis after PCI.8,9 However, in most European countries, less than half of eligible patients participate in center-based CR.10 Compared with center-based CR, home-based CR can promote patient participation and has the same benefits as center-based CR in improving patients functional capacity and quality of life and reducing the risk of death.11 However, poor adherence to home-based CR remains problematic, which may be because patients preferences are not included in the home-based CR program during the long-term and self-helping process. A new type of decision-making model12shared decision-making (SDM)requires information sharing between the doctor and the patient and incorporates patients preferences into the decision-making process. Continue reading →

Grief is a strong emotion, but it is an eventuality of stress. In fact, most negative emotions are expressed when a person is said to be stressed. Continue reading →